The neuronal Golgi apparatus is fragmented in transgenic mice expressing a mutant human SOD1, but not in mice expressing the human NF-H gene

Journal of the Neurological Sciences

Volumn 173, Issue 1, 2000, Pages 63-72

  Stieber, Anna ^a   Gonatas, Jacqueline O ^a   Collard, Jean Francois ^b   Meier, Jurgen ^b   Julien, Jean Pierre ^b   Schweitzer, Peter ^c   Gonatas, Nicholas K ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c JACKSON LABORATORY   (United States)

Author keywords

Golgi apparatus; Neurofilaments; SOD1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; NEUROFILAMENT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; GOLGI COMPLEX; IMMUNOCYTOCHEMISTRY; MOTONEURON; MOUSE; MUTANT; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; GOLGI APPARATUS; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MOTOR NEURONS; NEUROFILAMENT PROTEINS; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 0033972489     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00301-9     Document Type: Article

References (49)

1. Rowland L.P. Ten central themes in a decade of ALS research. Rowland L.P. Advances in neurology. 1991;3-23 Raven Press, New York.
2. Rosen D.R., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
3. Deng H.X., Hentati A., Tamer J.A., et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1993;1047-1051.
4. Siddique T., Deng H.-X. Genetics of amyotrophic lateral sclerosis. Hum Mol Genet. 5:1996;1465-1470.
5. Gurney M.E., Pu H., Chiu A.Y., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
6. Figlewicz D.A., Krizus A., Martinoli M.G., et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet. 3:1994;1757-1761.
7. Julien J.-P., Mushynski W.E. Neurofilaments in health and disease. Progress in nucleic acid research and molecular biology. 61:1998;1-23 Academic Press, New York.
8. Coté F., Collard J.F., Julien J.-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene. Cell. 73:1993;35-46.
9. Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:1993;23-33.
10. Mourelatos Z., Adler H., Hirano A., et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies. Proc Natl Acad Sci USA. 87:1990;4393-4395.
11. Gonatas N.K., Stieber A., Mourelatos Z., et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol. 140:1992;731-737.
12. Mourelatos Z., Yachnis A., Rorke L., et al. The Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Ann Neurol. 33:1993;608-615.
13. Mourelatos Z., Hirano A., Rosenquist A., Gonatas N.K. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in β,β′-iminodipropionitrile axonopathy. Am J Pathol. 144:1994;1288-1300.
14. Mourelatos Z., Gonatas N.K., Stieber A., et al. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA. 93:1996;5472-5477.
15. Fujita Y., Okamoto K., Sakurai A., et al. Fragmentation of the Golgi apparatus of Betz cells in patients with amyotrophic lateral sclerosis. J Neurol Sci. 163:1999;81-85.
16. Robbins E., Gonatas N.K. Histochemical and ultrastructural studies on HeLa cell cultures exposed to spindle inhibitors with special reference to the interphase cell. J Histochem Cytochem. 12:1964;704-711.
17. Kreis T.E., Goodson H.V., Perez F., Ronnholm R. Golgi apparatus-cytoskeleton interactions. Berger E.G., Roth J. The Golgi apparatus. 1997;179-194 Birkhauser, Basel, Switzerland.
18. Hammerschlag R., Stone G.C., Bolen F.A., et al. Evidence that all newly synthesized proteins destined for fast axoplasmic transport pass through the Golgi apparatus. J Cell Biol. 93:1982;568-575.
19. Gonatas N.K. Contributions to the physiology and pathology of the Golgi apparatus. Am J Pathol. 145:1994;751-761.
20. Dal Canto M.C., Gurney M.E. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. 93:1997;537-550.
21. Tu P.H., Gurney M.E., Julien J.-P., et al. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab Invest. 76:1997;441-456.
22. Gonatas N.K. The Golgi apparatus in disease. Berger E.G., Roth J. The Golgi apparatus. 1997;247-273 Birkhauser, Basel, Switzerland.
23. Gonatas J.O., Mezitis S.G.E., Stieber A., et al. MG-160: A novel sialoglycoprotein of the medial cisternae of the Golgi apparatus. J Biol Chem. 264:1989;646-653.
24. Croul S., Mezitis S.G.E., Stieber A., et al. Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a novel sialoglycoprotein of the medial cisternae of rat Golgi apparatus. J Histochem Cytochem. 38:1990;957-963.
25. Stieber A., Mourelatos Z., Gonatas N.K. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am J Pathol. 148:1996;415-426.
26. Graham R.C., Karnovsky M.J. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem. 14:1966;291-302.
27. Brown W.J., Farquhar M.G. Immunoperoxidase methods for the localization of antigens in cultured cells and tissue sections by electron microscopy. Methods Cell Biol. 31:1989;553-569.
28. Anthony C., Huchet M., Changeaux J.P., Cartaud J. Developmental regulation of membrane traffic organization during synaptogenesis in mouse diaphragm muscle. J Cell Biol. 130:1995;959-968.
29. Holleran E.A., Holbaur E.L. Speculating about spectrin: new insights into the Golgi-associated cytoskeleton. Trends Cell Biol. 8:1988;26-29.
30. Borchelt D.R., Lee M.K., Slunt H.S., et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA. 91:1994;8292-8296.
31. Collard J.P., Coté J.-F., Julien J.-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
32. Zhang B., Tu P.-H., Abtahian F., Trojanowski J.Q., Lee V.M.-Y. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol. 139:1997;1307-1315.
33. Rouleau G.A., Clark A.W., Rooke K., et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol. 39:1996;128-131.
34. Tu P.-H., Raju P., Robinson K.A., et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoplasmic pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA. 93:1996;3155-3160.
35. Couillard-Despress S., Zhu Q., Wong P.C., et al. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc Natl Acad Sci USA. 95:1998;9626-9630.
36. Williamson T.L., Bruijn L.I., Zhu Q., et al. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA. 95:1998;9631-9636.
37. Hirano A., Nakano I., Kurland L.T., et al. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 42:1984;471-480.
38. Mizusawa H., Matsumoto S., Yen S.-H., et al. Focal accumulation of phosphorylated neurofilaments within anterior horn cells in familial amyotrophic lateral sclerosis. Acta Neuropathol. 79:1989;37-43.
39. Hirano A., Inoue B. Early pathological changes of amyotrophic lateral sclerosis. Electron microscopic study of chromatolysis, spheroids and Bunina bodies. Neurol Med (Tokyo). 13:1980;128-160.
40. Gambetti P., Shecket G., Ghetti B., et al. Neurofibrillary changes in human brain. An immunocytochemical study with neurofilament antiserum. J Neuropathol Exp Neurol. 42:1983;69-79.
41. Borchelt D.R., Guarnieri M., Wong P.C., et al. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem. 270:1995;3234-3238.
42. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesent D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
43. m for hydrogen peroxide. Proc Natl. Acad Sci USA. 93:1996;5709-5714.
44. Bruijn L.I., Houseweart M.G., Kato S., et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1998;1851-1854.
45. Ischiropoulos H., Zhu L., Chen J., et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys. 298:1992;431-437.
46. Beckman J.S., Ischiropoulos H., Zhu L., et al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrate. Arch Biochem Biophys. 298:1992;438-445.
47. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
48. 2. Arch Biochem Biophys. 352:1998;237-239.
49. Eyer J., Cleveland D.W., Wong P.C., Peterson A.C. Pathogenesis of two axonopathies does not require neurofilaments. Nature. 391:1998;584-587.